Counterfactual Tumor Growth Prediction on PK-PD tumor growth simulator (test) benchmark leaderboard · SOTA2 Research

Counterfactual Tumor Growth Prediction on PK-PD tumor growth simulator (test)

0.7RMSECRN

Evaluation Results

Method	Links
CRN2026.04		0.7	0.1
CT2026.04		0.72	0.15
CRN2026.04		0.78	0.12
GNet2026.04		0.78	0.14
RMSN2026.04		0.8	0.11
CT2026.04		0.82	0.15
GNet2026.04		0.82	0.11
RMSN2026.04		0.84	0.14
CRN2026.04		0.86	0.14
CT2026.04		0.87	0.15
CDM2026.04		0.88	0.08
CDM2026.04		0.89	0.07
CRN2026.04		0.93	0.18
CT2026.04		0.93	0.23
CDM2026.04		0.95	0.08
RMSN2026.04		0.95	0.12
GNet2026.04		1.04	0.15
GNet2026.04		1.05	0.16
RMSN2026.04		1.09	0.17
CT2026.04		1.19	0.35
GNet2026.04		1.31	0.22
RMSN2026.04		1.35	0.23
CRN2026.04		1.37	0.25
RMSN2026.04		1.39	0.3
GNet2026.04		1.49	0.28
CDM2026.04		1.5	0.2
CT2026.04		1.58	0.33
CDM2026.04		1.61	0.14
RMSN2026.04		1.73	0.41
CRN2026.04		1.74	0.35
CDM2026.04		1.78	0.26
CT2026.04		1.91	0.54
GNet2026.04		1.96	0.41
CRN2026.04		2.07	0.46
CDM2026.04		2.14	0.37
CT2026.04		2.35	0.7
RMSN2026.04		2.38	0.6
CDM2026.04		2.41	0.5
CRN2026.04		2.64	0.68
GNet2026.04		2.67	0.61
CDM2026.04		2.69	0.61
CDM2026.04		2.95	0.75
CRN2026.04		3.01	0.81
RMSN2026.04		3.06	0.79
GNet2026.04		3.07	0.79
RMSN2026.04		3.12	0.92
GNet2026.04		3.2	0.81
CRN2026.04		3.33	0.94
CT2026.04		3.36	0.93
CDM2026.04		3.43	0.92
CDM2026.04		3.45	0.83
CDM2026.04		3.5	0.95
CDM2026.04		3.62	0.87
CDM2026.04		3.73	0.91
RMSN2026.04		3.82	1.09
CRN2026.04		3.89	1.07
GNet2026.04		3.94	1.04
GNet2026.04		3.98	1.12
GNet2026.04		4.05	1.15
CDM2026.04		4.09	0.98
GNet2026.04		4.09	1.12
RMSN2026.04		4.13	1.23
RMSN2026.04		4.19	1.26
GNet2026.04		4.21	1.21
CRN2026.04		4.27	1.21
CT2026.04		4.34	1.38
CRN2026.04		4.42	1.33
CRN2026.04		4.44	1.28
CRN2026.04		4.47	1.4
CT2026.04		4.48	1.3
RMSN2026.04		4.49	1.25
RMSN2026.04		4.49	1.29
CRN2026.04		4.55	1.4
GNet2026.04		4.57	1.3
CT2026.04		4.79	1.32
CT2026.04		4.85	1.36
CT2026.04		4.87	1.42
RMSN2026.04		4.9	1.34
CT2026.04		5.35	1.6
CT2026.04		5.86	1.7